BioGaia AB : Year-end report 2011
(Thomson Reuters ONE) -
BioGaia AB Year-end report 2011
(Figures in brackets refer to the same period of last year)
2011
- Net sales reached SEK 315.0 million (236.0), an increase of SEK 79.0
million (33%). Excluding foreign exchange effects, net sales grew by 40%.
- Operating profit was SEK 103.2 million (56.3), an improvement of SEK 46.9
million (83%). Excluding foreign exchange effects, operating profit rose by
101%.
- Profit before tax was SEK 108.9 million (69.7), an increase of SEK 39.2
million (56%). Net financial items include a foreign exchange gain of SEK 2.5
million (12.4) arising from foreign exchange contracts in EUR.
- Profit after tax was SEK 79.5 million (47.2), an improvement of SEK 32.3
million (68%).
- Earnings per share amounted to SEK 4.42 (2.74).
- The period's total cash flow was SEK 24.7 million (47.5). During the year
BioGaia paid dividends of SEK 34.5 million (25.8) and corporate tax of SEK 35.8
million (0), of which SEK 18.4 million refers to the 2010 financial year. Cash
and cash equivalents at 31 December 2011 totalled SEK 171.5 million (146.9).
- The Board proposes that the upcoming AGM approve an ordinary dividend of
SEK 1.26 and an extraordinary dividend of SEK 2.74, equal to a total dividend of
SEK 4.00 per share.
Fourth quarter 2011
- Net sales reached SEK 82.4 million (62.8), an increase of SEK 19.6 million
(31%). Excluding foreign exchange effects, net sales grew by 32%.
- Operating profit was SEK 23.8 million (16.2), an improvement of SEK 7.6
million (47%). Excluding foreign exchange effects, operating profit rose by 51%.
- Profit before tax was SEK 29.6 million (18.6), an increase of SEK 11.0
million (59%). Net financial items include a foreign exchange gain of SEK 4.8
million (1.9) arising from foreign exchange contracts in EUR.
- Profit after tax was SEK 21.8 million (12.9) , an improvement of SEK 8.9
million (69%).
Key events in the fourth quarter of 2011
- Agreement for the sale of drops and tablets in Venezuela and Puerto Rico.
- Results from two Helicobacter pylori studies
"Last year was yet another year of strong growth in sales. This applies both to
finished products, in all markets, and our component products in Europe and
Asia. It is also encouraging to see that our focused efforts in Japan and the
USA have yielded results that we now continue to build on," says Peter
Rothschild, President of BioGaia.
BioGaia has published this information in accordance with the Swedish Securities
Market Act. The information was issued for publication on 10 February
2012, 8:00 a.m.
Year-end report 2011:
http://hugin.info/86913/R/1584530/495719.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: BioGaia AB via Thomson Reuters ONE
[HUG#1584530]
Unternehmensinformation / Kurzprofil:
Datum: 10.02.2012 - 08:00 Uhr
Sprache: Deutsch
News-ID 113273
Anzahl Zeichen: 3656
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 170 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioGaia AB : Year-end report 2011"
steht unter der journalistisch-redaktionellen Verantwortung von
BioGaia AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
